Declared Rationale for Cannabis Use Before and After Legalization for Nonmedical Use: A Longitudinal Study of Community Adults in Ontario

被引:4
|
作者
AminiLari, Mahmood [1 ,2 ]
Busse, Jason W. [1 ,2 ,3 ,4 ,5 ]
Turna, Jasmine [4 ,5 ,6 ,7 ]
MacKillop, James [4 ,5 ,6 ,7 ,8 ]
机构
[1] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, 1280 Main St West, Hamilton, ON, Canada
[2] McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON, Canada
[3] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada
[4] St Josephs Healthcare, Hamilton, ON, Canada
[5] McMaster Univ, Michael G Degroote Ctr Med Cannabis Res, Hamilton, ON, Canada
[6] McMaster Univ, Peter Boris Ctr Addict Res, Hamilton, ON, Canada
[7] St Joseph Healthcare, Hamilton, ON, Canada
[8] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada
关键词
patterns; cannabis use; legalization; Canada; MEDICAL CANNABIS; SUBSTITUTE; ACCESS;
D O I
10.1089/can.2021.0128
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: To examine the proportion of individuals using cannabis for medical purposes who reported nonmedical use of cannabis after it became legal to do so.Materials and Methods: We acquired data from the Population Assessment for Tomorrow's Health, the Cannabis Legalization Surveillance Study on a subpopulation of participants residing in Hamilton, Ontario, Canada, who reported using cannabis for medical purposes. Specifically, we acquired data 6 months before, and again 6 months after, legalization of cannabis for nonmedical purposes. We constructed a logistic regression model to explore the association between potential explanatory factors and endorsing exclusively nonmedical use after legalization and reported associations as odds ratios and 95% confidence intervals.Results: Our sample included 254 respondents (mean age 33 +/- 13; 61% female), of which 208 (82%) reported both medical and nonmedical use of cannabis (dual motives) before legalization for nonmedical purposes, and 46 (18%) reported cannabis use exclusively for medical purposes. Twenty-five percent (n=63) indicated they had medical authorization to use medical cannabis, of which 37 (59%) also endorsed nonmedical use. After legalization of nonmedical cannabis, similar to 1 in 4 previously exclusive cannabis users for medical purposes declared dual use (medical and nonmedical), and similar to 1 in 4 previously dual users declared exclusively nonmedical use of cannabis. No individual with medical authorization reported a change to exclusively nonmedical use after legalization. Our adjusted regression analysis found that younger age, male sex, and lacking authorization for cannabis use were associated with declaring exclusively nonmedical use of cannabis after legalization. Anxiety, depression, impaired sleep, pain, and headaches were among the most common complaints for which respondents used cannabis therapeutically. Most respondents reported using cannabis as a substitute for prescription medication at least some of the time, and approximately half reported using cannabis as a substitute for alcohol at least some of the time.Conclusions: In a community sample of Canadian adults reporting use of cannabis for medical purposes, legalization of nonmedical cannabis was associated with a substantial proportion changing to either dual use (using cannabis for both medical and nonmedical purposes) or exclusively nonmedical use. Younger men without medical authorization for cannabis use were more likely to declare exclusively nonmedical use after legalization.
引用
收藏
页码:1133 / 1139
页数:7
相关论文
共 50 条
  • [31] Medically Recommended vs Nonmedical Cannabis Use Among US Adults
    Han, Beth
    Compton, Wilson M.
    Einstein, Emily B.
    Volkow, Nora D.
    JAMA PSYCHIATRY, 2025, 82 (03) : 319 - 321
  • [32] Limited use of medicinal cannabis but for labeled indications after legalization
    Erkens, JA
    Janse, AFC
    Herings, RMC
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2005, 14 (11) : 821 - 822
  • [33] Challenges in minimizing the adverse effects of cannabis use after legalization
    Wayne Hall
    Social Psychiatry and Psychiatric Epidemiology, 2015, 50 : 1013 - 1015
  • [34] Drug use in Canadian patients with trauma after cannabis legalization
    Ball, Ian M.
    Priestap, Fran
    Parry, Neil
    Pace, Jacob
    Vogt, Kelly N.
    CANADIAN JOURNAL OF SURGERY, 2021, 64 (04) : E403 - E406
  • [35] Challenges in minimizing the adverse effects of cannabis use after legalization
    Hall, Wayne
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2015, 50 (07) : 1013 - 1015
  • [36] Prevalence of Cannabis Use in Youths After Legalization in Washington State
    Dilley, Julia A.
    Richardson, Susan M.
    Kilmer, Beau
    Pacula, Rosalie Liccardo
    Segawa, Mary B.
    Cerda, Magdalena
    JAMA PEDIATRICS, 2019, 173 (02) : 192 - 193
  • [37] A longitudinal study of cannabis use increasing the use of asthma medication in young Norwegian adults
    Jørgen G. Bramness
    Tilmann von Soest
    BMC Pulmonary Medicine, 19
  • [38] Marijuana Use in Pregnant Teens Before and After Legalization
    Rodriguez, Christina E.
    Sheeder, Jeanelle
    Metz, Torri D.
    REPRODUCTIVE SCIENCES, 2016, 23 : 282A - 282A
  • [39] A longitudinal study of cannabis use increasing the use of asthma medication in young Norwegian adults
    Bramness, Jorgen G.
    von Soest, Tilmann
    BMC PULMONARY MEDICINE, 2019, 19 (1)
  • [40] Trends of cannabis use and related harms before and after legalization for recreational purpose in a developing country in Asia
    Rasmon Kalayasiri
    Suriyan Boonthae
    BMC Public Health, 23